Results

Total Results: 1,187 records

Showing results for "weeks".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
    September 10, 2012 - Thomas, 2009, in which the follow up was 6 months rather than 4 weeks as stated), and in the numbers … the table emphasized the 4-week results over the 26-week since more results were only reported at 4 weeks … His article suggests that his main outcomes were reported at 26 weeks, however, so we modified the … Results after applying Buteyko techniques for 12 weeks • Reliever usage – median reduction of 86% • … Results after applying Buteyko techniques for 12 weeks • Reliever usage – median reduction of 86% •
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
    October 22, 2012 - Cough that lasts more than 4 weeks in children younger than 14 years of age or more than 8 weeks in … in children younger than 14 years of age or more than 8 weeks in adolescents and adults 14 years … in children younger than 14 years of age or more than 8 weeks in adolescents and adults 14 years of … in children younger than 14 years of age or more than 8 weeks in adolescents and adults 14 years of … if <14 years of age or 8 weeks if ≥14 years of age, or as stated by study authors) o Patients with
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - therapy for outcomes related to pain, function, pain relief satisfaction, and quality of life up to 4 weeks … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks None Settings ED, physician’s office, hospital None Study design Original
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
    October 01, 2012 - (a)After 24 weeks’ gestation? (b) During the first trimester and up to 24 weeks’ gestation? … at 24–28 weeks; another screened a group of participants after 37 weeks; one study screened before … 24 weeks; another screened women at risk between 14 and 16 weeks, with normal women screened at the … usual 24–28 weeks; and one study screened between 16 and 20 weeks or between 17 and 21 weeks followed … , and another study screened women at high risk at 18–20 weeks and others at 28–30 weeks.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-executive-summ.pdf
    April 01, 2025 - mindfulness-based interventions) and for longer-term treatment effects in general (e.g., greater than 24 or 48 weeks … treatment as usual + = low strength of evidence; ++ = moderate strength of evidence a Short term: ≤24 weeks … ; intermediate term: 25-47 weeks; long term: ≥48 weeks In trials of pharmacotherapy, stimulants and
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - and Detroit areas with history of PcR+ and who were tested for IgG Abs to anti-S protein at least 2 weeks … responders ≥18 yrs old with history of PCR+ who were tested for IgG Abs to anti-S protein at least 2 weeks … after symptom onset If during the previous 2 weeks before survey completion they reported new onset … : 24 (3.2)* RBD IgG ELISA Zydus diagnostics, India Time from infection 0-7 days 10-28 days 6 to 10 weeks … ; Antibody testing every 4 weeks; Questionnaires re symptoms and exposures every 2 weeks.
  7. S89 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
    October 01, 2007 - windows to vaccinated time windows using hierarchical rules as follows: age within 2 years; week within 8 weeks … Williams & Wilkins S91 RESULTS Patterns of Vaccine Exposure and Preventive Visit Use After 106 weeks … case of facial paralysis occurred in the control group, reducing the LLR to 0.52, and in subsequent weeks … As more weeks elapsed, no additional cases occurred, and the number of expected cases increased, causing
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - specified duration of four weeks; that trial’s duration was 14 days. … These were largely excluded because study duration was less than four weeks. … Note, page 33, line 8, ‘Eligible drug trials rarely lasted longer than 6 weeks.’ … Therefore, the target of trials of at least 4 weeks duration seems inappropriate. … These were largely excluded because study duration was less than four weeks.
  9. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
    February 02, 2022 - individual from complications related to pregnancy or childbirth that occur during pregnancy or within 6 weeks … following phases: immediate postpartum (first 24 hours after delivery), early postpartum (up to 6 weeks … Mental health coverage ● Access to substance use disorder care ● Medicaid coverage – up to 6 weeks … G., Weeks, L. D., & McLemore, M. R. (2020). … Pregnancy/birthing is defined as a sustained pregnancy through at least 20 weeks gestation.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - This study reported a significant association between treatment site and retention at 20 weeks (p=0.05 … Weeks retained: Number of weeks between induction and the last day the participant was assessed … Initial value $12, maximum $174, $30 bonus for 3 weeks of adherence, earnings were exchanged for … Buprenorphine injections (weekly during weeks 1 – 11, monthly during weeks 12 – 24) + daily SL placebo … vs Placebo injections (weekly during weeks 1 – 11, monthly during weeks 12 – 24) + daily SL
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    May 29, 2025 - $ •$ Inpatient$cognitive$rehab$ o$ Inpatient,$6$weeks$(hours/week$not$reported)$ •$ Comprehensive … $neurorehabilitation$ o$ Inpatient,$37.5$hours/week$for$6$weeks$ We$identified$no$studies$meeting … $mix$(balanced,$ interpersonal,$and$cognitive)$ o$ Outpatient$rehab$center,$5$ hours/week$for$4$weeks … $ •$ Inpatient$cognitive$rehab$ o$ Inpatient,$6$weeks$(hours/week$ not$reported)$ •$ Comprehensive … $neurorehabilitation$ o$ Inpatient,$37.5$hours/week$for$ 6$weeks$ We$identified$no$studies$meeting
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
    September 13, 2012 - standard definition of a chronic venous leg ulcer, which is the presence of an active ulcer for 6 weeks … Long-term recurrent reflux and ulceration Timing • Durations with 4 or more weeks of followup … (KQs 1, 2, & 3) Intermediate outcomes  Wound healing at 4 weeks  Pain  Quality of wound bed …  Wound recurrence at 24 weeks and at 1 year  Quality of life  Mortality  Functional status … Timing and Setting • We will include studies with at least 4 weeks of followup • We will include
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
    June 11, 2014 - 24 hours of birth, or secondary/delayed/late, occurring more than 24 hours post-birth to up to 12 weeks … postpartum following pregnancy >24 weeks’ gestation • KQ4: Women with stabilized PPH and acute blood … postpartum following pregnancy of >24 weeks’ gestation. … postpartum following pregnancy >24 weeks’ gestation and include all birth settings (hospital, birth … postpartum following pregnancy of >24 weeks’ gestation Intermediate outcomes § Blood loss
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
    February 01, 2012 - In the second model, Phe and IQ were measured concurrently (within 6 weeks of each other). … The study reported that timing of maternal metabolic control, defined as the number of weeks gestation … half of treated participants (32 to 50 percent) at dosages of 5 to 20 mg/kg/day and for up to 22 weeks … At a dosage of 20 mg/kg/day over 10 weeks, participants in the treatment group increased their Phe … The trials were short, with treatment between 1 and 8 weeks, and dosages ranged from 250 mg/kg/day
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - , Median) Pain Duration, Months Psychiatric Comorbidity % N Interventions Dose Treatment Duration (Weeks … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - The therapy is typically administered for 24 weeks in patients infected with HCV genotype 2 or 3 and … may be extended up to 48 weeks for patients with HCV genotype 1.5,6 The effects of antiviral therapies … Adults undergoing:  HCV monotherapy  Adults undergoing long-term HCV maintenance therapy (>52 weeks … Cross-sectional  Case series Intervention Duration Any Minimum Followup KQs 1–3  12 weeks … vs 72 weeks of pegylated interferon and ribavirin.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
    August 07, 2018 - Given that depressive episodes are typically of longer duration than mania (i.e. at least two weeks … For acute mania treatment, outcomes were grouped by 3-4 weeks and then final measurement (generally … 6 to 12 weeks) if available.” … While the protocol stated we would abstract outcomes at the 3 weeks and final time frame for acute … Outcomes at times different than 3 weeks are specifically noted.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
    November 27, 2012 - , in some patients with early virologic response, compared with 48 weeks for dual therapy. … Executive Summary (ES-2) Boceprevir has a duration of therapy of 28 weeks, as opposed to 24 weeks … period of dual therapy followed by 24 weeks of triple therapy with boceprevir. … of dual therapy” should read “…randomized to 24 compared with 28 weeks of dual therapy”. … or 28 additional weeks of therapy.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
    June 01, 2010 - Systematic Review Background Preterm birth is the delivery of an infant before the completion of 37 weeks … restrict use of 17-OHP to women with a documented history of a previous spontaneous birth at less than 37 weeks … Key Questions Question 1 In pregnant women who are at risk for preterm birth (< 37 weeks estimated … Key Question Fetal/neonatal outcomes: • Gestational age at birth, including preterm birth (< 37 weeks … ; cut points such as < 28, < 32, and < 34 weeks; and weeks of gestation among preterm births, as a
  20. effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
    April 09, 2020 - Students without specific contact with cases Not reported, other than as part of interventions 6 weeks … Students without specific contact with cases Not reported, other than as part of interventions 6 weeks … HCWs Not reported 4 weeks A. 33.6 B. 31.3 C. 34.2 A. 85.7% B. 86.8% C. 83.9% A. 4.1% B. 3.1% C. 4.0% … HCWs HCWs in the cloth mask group asked to wash masks with soap and water every day 4 weeks A: 36 B: … Unspecified infection prevention policies were followed at each study site. 12 weeks A: 43 B: 43 A: 85.0

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: